BioNTech SE (BNTX) Reports Q4 EPS of EUR12.18

BioNTech SE (NASDAQ: BNTX) reported Q4 EPS of EUR12.18. Revenue for the quarter came in at EUR5.53 billion.

Estimated BioNTech COVID-19 vaccine revenues for the full 2022 financial year €13 billion - €17 billion

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Casey's General Stores (CASY) Tops Q1 EPS by 69c
• Meta launches Muse, a personal AI agent with secure virtual machine